MK
Michelle Keefe
Chief Executive OfficerDirector

Michelle Keefe insider trades: Syneos Health (SYNH) stock sales

Chief Executive Officer, Syneos Health Last trade Jul 18, 2022 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2020
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michelle reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 18, 2022SYNH↓ Sell10b5-1$607K
Apr 15, 2021SYNH↓ Sell10b5-1$224K
Mar 31, 2021SYNH↓ Sell10b5-1$156K
Jan 25, 2021SYNH↓ Sell10b5-1$303K
Nov 18, 2020SYNH↓ Sell10b5-1$106K
Jul 6, 2020SYNH↓ Sell10b5-1$89K
May 20, 2020SYNH↓ Sell10b5-1$150K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michelle Keefe's insider trades

Michelle Keefe is Chief Executive Officer at Syneos Health (SYNH). Since May 20, 2020, Michelle has reported no open-market purchases and 7 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

7 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include shares withheld for taxes (15 filings), grants and awards (11 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SYNH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.